Trials / Recruiting
RecruitingNCT06172842
Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Echocardiography | Multi-modality echocardiography |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-12-01
- Completion
- 2026-10-01
- First posted
- 2023-12-15
- Last updated
- 2024-01-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06172842. Inclusion in this directory is not an endorsement.